Prosthetic Valves - Harvard University
Download
Report
Transcript Prosthetic Valves - Harvard University
Echocardiographic
Evaluation of Prosthetic
Heart Valves
Patricia Tung, M.D.
February 10, 2010
Objectives
Types
of prostheses
Prosthetic dysfunction
Echocardiographic surveillance of
prostheses
Types of Prostheses
Mechanical
valves
Tissue valves
Homograft valves
Mechanical Valves
Tissue Valves
Homograft Valves
Objectives
Types
of prostheses
Prosthetic dysfunction
Echocardiographic surveillance of
prostheses
Mechanisms of Prosthetic Valve
Dysfunction
Structural
failure
Stenosis
Regurgitation
Thromboembolic
complications
Endocarditis
Patient
Prosthesis Mismatch
Structural Failure Bioprosthetics
Cohn et al.
Ann Thorac Surg,
1998.
Homograft Dysfunction
Subject
to severe tissue calcification
Usually reserved for complex aortic root
abscesses
Hyperlipidemia accelerates prosthesis
calcification
Secondary prevention may slow this
process
Physical Exam Findings
Echocardiographic Evaluation
TTE
valve area and regurgitation
exclude significant obstruction
Flow velocity is crucial measurement
Often inadequate for infection or small
structural changes (strut fracture, small
vegetation, paravalvular leak)
TEE
inspection of valve apparatus and seating
may not accurately quantify valve flow
velocities
Normal Appearance PV
Normal Doppler Clicks
Normal Doppler Flow Patterns
Fluid Dynamics and Velocities
Normal Finding: Regurgitation
Pathologic Regurgitation
Characterized by:
An eccentric or large jet
Marked variance on the color flow display
A jet that originates around the valve sewing
ring
Visualization of a proximal flow acceleration
region on the LV side of the mitral valve
Prosthetic Valve Regurgitation
Prosthetic Valve Stenosis
Pressure gradients
- Calculated using the Bernoulli equation (4v2)
- Good correlation when validated against
invasive pressure measurements
- mechanical valves, especially bileaflet, result
in overestimation of the gradient due to
differing fluid dynamics
Prosthetic Aortic Valve Area
Prosthetic AVA: Velocity Ratio
Measure
velocity increase across valve
Ratio of outflow tract velocity/aortic jet
velocity reflects degree of stenosis
Ratio = 1 if no obstruction present
Given inherent stenosis, normal range is
0.35 to 0.5 for aortic prosthesis
Prosthetic Mitral Valve Area
Can
be estimated using the pressure halftime approach as for native mitral valve
stenosis.
The expected half-time for a PV is longer
than with a native valve.
Prosthetic Valve Thrombosis
TEE is often negative if
the thrombi are small or if
new thrombus has not
formed since the initial
embolic event.
Thus an embolic event in
a patient with a prosthetic
valve (esp mechanical)
must be presumed to be
related to the PV even if
the TEE is negative.
Prosthetic Valve Endocarditis
Difficult
to detect with TTE
Often involves sewing ring and annulus,
resulting in paravalvular abscess rather
than a discrete vegetation
Prosthetic Valve Endocarditis
Patient Prosthesis Mismatch
Size
of prosthesis results in inadequate
blood flow given metabolic demands
Prosthesis itself functions well
Indexed effective orifice area < or =
0.85cm2/m2
Predicts high transvalvular gradients,
persistent LVH and increased rate of
cardiac events following AVR
Objectives
Types
of prostheses
Prosthetic dysfunction
Echocardiographic surveillance of
prostheses
Recommended Surveillance
Baseline
echocardiogram 6-8 weeks
postoperatively
Routine echocardiographic surveillance
annually thereafter
Evaluate for
Regression of hypertrophy or dilation
Recovery of LV systolic function
Changes in PA pressures
Summary
Prosthetic valve dysfunction is well detected by
echocardiography
Dysfunction includes
Structural failure
Thromboembolic complications
Endocarditis
PPM
Distinguishing normal from pathologic function
can be challenging; most useful is comparison to
baseline post-prosthesis
References
Otto, C. Textbook of Clinical Echocardiography, Fourth Edition 2009.
Libby et al. Braunwald’s Heart Disease. Eighth Edition 2008.
Pibarot, P and Dumesnil JG. Prosthesis-patient mismatch: definition,
clinical impact, and prevention. Heart 2006;92:1022-1029
Bonow RO, Carabello BA, Chatterjee K, et al: ACC/AHA 2006
guidelines for the management of patients with valvular heart
disease: A report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines (writing
committee to revise the 1998 Guidelines for the Management of
Patients with Valvular Heart Disease): Developed in collaboration
with the Society of Cardiovascular Anesthesiologists: endorsed by
the Society for Cardiovascular Angiography and Interventions and
the Society of Thoracic Surgeons. Circulation 2006; 114:e84.